Task: Answer the multiple choice question.
Query: Which drug exhibits a 5.130% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: CN1CCN(CC(O)COCc2ccc3c(c2)OCO3)CC1.Cl
b: COc1ccc(/C=N/N=C2/NC(=O)C(CC(=O)NC(N)=O)S2)cc1
Answer: b. COc1ccc(/C=N/N=C2/NC(=O)C(CC(=O)NC(N)=O)S2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(/C=N/N=C2/NC(=O)C(CC(=O)NC(N)=O)S2)cc1
COc1ccc(/C=N/N=C2/NC(=O)C(CC(=O)NC(N)=O)S2)cc1
N-carbamoyl-2-[(2Z)-2-[(E)-(4-methoxyphenyl)methylidenehydrazinylidene]-4-oxo-1,3-thiazolidin-5-yl]acetamide